[Immuno-Oncology Newsletter - Edition 7] From RNA to TME: Tools & Insights to Accelerate Immuno-Oncology Research

Immuno-Oncology Insights: The Rise of Gene Therapy

Tebubio is heading to the AACR Annual Meeting 2025 to present our latest poster on next-generation RNA delivery systems for cancer research. Featuring fluorescent lipid nanoparticles (LNPs) designed for real-time imaging and precise RNA tracking, our approach brings new depth to personalized in vitro oncology models.

Through our CRS (Contract Research Services) platform, we offer end-to-end support—from custom RNA production and encapsulation to in vitro validation—empowering pharma, biotech, and academic teams to accelerate RNA-based therapeutic development. 

Visit us to see how we’re helping shape the future of RNA-based therapeutics ! 

Blog

Decoding the Tumor Microenvironment: Advanced Proteomics for Biomarker Discovery & Immunotherapy insights.

Watch our latest webinar, co-organized with our partner RayBiotech, and explore the complex landscape of the Tumor Microenvironment (TME).
Discover how advanced multiplex proteomic tools, such as high-density antibody arrays covering 8,000+ proteinscan accelerate biomarker discovery, predict patient responses, and support the development of next-generation immunotherapies. 

Don’t miss this opportunity to take your oncology research further!

Need clarity on your target pathway?

Whether you're validating a target or screening compounds, identifying the right biomarkers is critical—but not always straightforward.

Tebubio’s laboratory experts can help you design and execute tailored biomarker mapping studies with full analytical support.

Explore our Biomarker Mapping Services and start with the right data.

Stimulus solutions

Revolutionizing Cancer Immunotherapy with Bispecific Antibodies

Bispecific T-cell engagers (BiTe®) are opening new frontiers in oncology by linking immune cells to tumor targets with unmatched precision.

In this article, explore how antibody engineering is accelerating cancer treatment innovation, and discover how our partner BPS Bioscience supports your research with ready-to-use tools for bispecific antibody development and validation.

Models solutions

Struggling to find reliable immune cells for your Immuno-Oncology models?

Reproducibility, cell purity, and donor consistency are real hurdles in functional assays. That’s why our experts at Tebubio have selected a dedicated range of fresh and cryopreserved immune cells from iXCells Biotechnologies—tailored for drug discovery, cytotoxicity studies, and co-culture applications.

Discover which cell types can support your next breakthrough.

Analysis solutions

Improve tumor growth dynamics understanding with our tool box

At Tebubio, we provide advanced tools to better understand cancer cell dynamics for more effective drug development. Discover ProImaging’s high-performance labeling dye for precise tumor visualization (NIR–SWIR) and our ClickTech EdU Assay Kit for direct DNA synthesis measurement.

Combine these technologies to gain deeper insights into tumor growth and accelerate therapeutic innovation.

Optimize your immuno-oncology research today!

We facilitate Life Sciences Research daily, advancing Science for a brighter future with comprehensive biological solutions from top global suppliers to accelerate your research projects.

If you lack time or expertise, our CRS team can support you with mRNA production, cell line engineering, protein production, cellular studies, and biomarker analysis.

With Tebubio, concentrate your efforts and accelerate what’s most important to you: your research.

Stay Ahead in Immuno-Oncology

Subscribe to our monthly newsletter for the latest breakthroughs, expert insights, and exclusive updates in immuno-oncology.